News for Healthier Living

Immunotherapy Boosts Chemotherapy in Combating Stage 3 Colon Cancer

New research led by Mayo Clinic Comprehensive Cancer Center found that adding immunotherapy to chemotherapy after surgery for patients with stage 3 (node-positive) colon cancer -- and with a specific genetic makeup called deficient DNA mismatch repair (dMMR) -- was associated with a 50% reduction in cancer recurrence and death compared to chemotherapy alone.

June 1, 2025


June 3 2025

June 2 2025

June 1 2025

May 31 2025

May 30 2025

May 29 2025

May 28 2025

May 27 2025

May 26 2025

May 25 2025

May 24 2025

May 23 2025

May 22 2025

May 21 2025